Theratechnologies Stock Forecast, Price & News

-0.01 (-0.24 %)
(As of 05/11/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume86,227 shs
Average Volume191,255 shs
Market CapitalizationC$398.27 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TH News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

Theratechnologies logo

About Theratechnologies

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.


See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Year FoundedN/A

Sales & Book Value

Annual SalesC$65.76 million
Cash FlowC$0.59 per share
Book ValueC$0.43 per share





Market CapC$398.27 million
Next Earnings Date7/21/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.68 out of 5 stars

Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Theratechnologies (TSE:TH) Frequently Asked Questions

Is Theratechnologies a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Theratechnologies stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TH, but not buy additional shares or sell existing shares.
View analyst ratings for Theratechnologies
or view top-rated stocks.

What stocks does MarketBeat like better than Theratechnologies?

Wall Street analysts have given Theratechnologies a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Theratechnologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Theratechnologies' next earnings date?

Theratechnologies is scheduled to release its next quarterly earnings announcement on Wednesday, July 21st 2021.
View our earnings forecast for Theratechnologies

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc. (TSE:TH) released its quarterly earnings data on Thursday, February, 25th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $24.93 million for the quarter.
View Theratechnologies' earnings history

How has Theratechnologies' stock been impacted by Coronavirus?

Theratechnologies' stock was trading at C$3.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TH shares have increased by 40.3% and is now trading at C$4.21.
View which stocks have been most impacted by COVID-19

What price target have analysts set for TH?

2 brokers have issued 1 year price targets for Theratechnologies' shares. Their forecasts range from C$3.75 to C$3.75. On average, they anticipate Theratechnologies' stock price to reach C$3.75 in the next year. This suggests that the stock has a possible downside of 10.9%.
View analysts' price targets for Theratechnologies
or view top-rated stocks among Wall Street analysts.

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the following people:
  • Mr. Paul Lévesque, Pres, CEO & Director (Age 57, Pay $861.83k)
  • Mr. Philippe Dubuc M.B.A., MBA, Sr. VP & CFO (Age 54, Pay $318.54k)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 53, Pay $281.34k)
  • Dr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 58, Pay $357.28k)
  • Mr. Conor M. Walshe, Gen. Mang. of Theratechnologies Europe Limited (Age 48, Pay $370.51k)
  • Leah Gibson, Sr. Director of Investor Relations
  • Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 55)

Who are some of Theratechnologies' key competitors?

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), Theratechnologies (THERF), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Endeavour Mining (EDV), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and (AVO.TO) (AVO).

What is Theratechnologies' stock symbol?

Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."

How do I buy shares of Theratechnologies?

Shares of TH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Theratechnologies' stock price today?

One share of TH stock can currently be purchased for approximately C$4.21.

How much money does Theratechnologies make?

Theratechnologies has a market capitalization of C$398.27 million and generates C$65.76 million in revenue each year.

How many employees does Theratechnologies have?

Theratechnologies employs 54 workers across the globe.

What is Theratechnologies' official website?

The official website for Theratechnologies is www.theratech.com.

Where are Theratechnologies' headquarters?

Theratechnologies is headquartered at 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The company can be reached via phone at +1-514-3367800.

This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.